Himss next earnings cover Q1 2026, before One Medicals GLP-1 launch
As for clinical outcomes, in the T2DM group, there was a significant reduction in HbA1c (decreased by 1.01% to 1.02%, placebo-adjusted) and a clinically meaningful decrease in body weight of 3.26% to 3.51% after 12 weeks of treatment
I would hate to scare somebody out of bettering their health just because I've got some bat wings on," she laughed
The most common side effects in the Phase 2 obesity trial were gastrointestinal: nausea, diarrhea, vomiting, and constipation
The FDA-approved maximum dose is 2.4 mg injected once weekly
When it gets oxidized, it becomes GS and two GS molecules come together, it becomes GSSG, which is the medical or the chemical term of this oxidized glutathione